Role of the T2Dx magnetic resonance assay in patients with suspected bloodstream infection: a single-centre real-world experience

BACKGROUND: T2Dx was approved by the US Food and Drug Administration for the rapid detection of a modified panel of ESKAPE bacterial species or Candida spp. causing bloodstream infection (BSI). PATIENTS AND METHODS: We performed a retrospective, observational study from January 1, 2018 to December 3...

Descripción completa

Detalles Bibliográficos
Autores principales: Quirino, Angela, Scaglione, Vincenzo, Marascio, Nadia, Mazzitelli, Maria, Garofalo, Eugenio, Divenuto, Francesca, Serapide, Francesca, Bruni, Andrea, Lionello, Rosaria, Pavia, Grazia, Costa, Chiara, Giancotti, Aida, Peronace, Cinzia, Longhini, Federico, Russo, Alessandro, Liberto, Maria Carla, Matera, Giovanni, Torti, Carlo, Trecarichi, Enrico Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805379/
https://www.ncbi.nlm.nih.gov/pubmed/35105333
http://dx.doi.org/10.1186/s12879-022-07096-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805379/
https://www.ncbi.nlm.nih.gov/pubmed/35105333
http://dx.doi.org/10.1186/s12879-022-07096-w

Ejemplares similares